Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2002 3
2003 2
2004 2
2005 4
2006 1
2007 2
2008 4
2009 4
2010 3
2011 4
2012 6
2013 8
2014 12
2015 11
2016 11
2017 9
2018 9
2019 8
2020 8
2021 7
2022 6
2023 9
2024 3

Text availability

Article attribute

Article type

Publication date

Search Results

120 results

Results by year

Filters applied: . Clear all
Page 1
Evaluation of the reproducibility of responses to nasal allergen challenge and effects of inhaled nasal corticosteroids.
Bauer RN, Xie Y, Beaudin S, Wiltshire L, Wattie J, Muñoz C, Alsaji N, Oliveria JP, Ju X, MacLean J, Sommer DD, Keith PK, Satia I, Cusack RP, O'Byrne PM, Sperinde G, Hokom M, Li O, Banerjee P, Chen C, Staton T, Sehmi R, Gauvreau GM. Bauer RN, et al. Among authors: gauvreau gm. Clin Exp Allergy. 2023 Nov;53(11):1187-1197. doi: 10.1111/cea.14406. Epub 2023 Oct 4. Clin Exp Allergy. 2023. PMID: 37794659
Refashioning dexpramipexole: A new horizon in eosinophilic asthma?
Cusack RP, Sulaiman I, Gauvreau GM. Cusack RP, et al. Among authors: gauvreau gm. J Allergy Clin Immunol. 2023 Nov;152(5):1092-1094. doi: 10.1016/j.jaci.2023.09.019. Epub 2023 Sep 26. J Allergy Clin Immunol. 2023. PMID: 37769877 No abstract available.
Anti-alarmin asthma therapies: where do we go from here?
Sulaiman I, Gauvreau GM. Sulaiman I, et al. Among authors: gauvreau gm. J Bras Pneumol. 2023 Jul 24;49(3):e20230220. doi: 10.36416/1806-3756/e20230220. J Bras Pneumol. 2023. PMID: 37493796 Free PMC article. No abstract available.
Protein expression of SARS-CoV-2 receptors ACE2 and TMPRSS2 in allergic airways after allergen challenge.
Whetstone CE, Ranjbar M, Cusack RP, Al-Sajee D, Omer H, Alsaji N, Ho T, Duong M, Mitchell P, Satia I, Keith P, Xie Y, MacLean J, Sommer DD, O'Byrne PM, Sehmi R, Gauvreau GM. Whetstone CE, et al. Among authors: gauvreau gm. Allergy. 2023 Nov;78(11):3010-3013. doi: 10.1111/all.15793. Epub 2023 Jun 25. Allergy. 2023. PMID: 37357419 No abstract available.
Inhaled anti-TSLP antibody fragment, ecleralimab, blocks responses to allergen in mild asthma.
Gauvreau GM, Hohlfeld JM, FitzGerald JM, Boulet LP, Cockcroft DW, Davis BE, Korn S, Kornmann O, Leigh R, Mayers I, Watz H, Grant SS, Jain M, Cabanski M, Pertel PE, Jones I, Lecot JR, Cao H, O'Byrne PM. Gauvreau GM, et al. Eur Respir J. 2023 Mar 9;61(3):2201193. doi: 10.1183/13993003.01193-2022. Print 2023 Mar. Eur Respir J. 2023. PMID: 36822634 Free PMC article. Clinical Trial.
120 results